Medicare Eligibility Verification for Infectious Disease Practices

Medicare eligibility verification is the process of confirming whether a patient has active coverage and reviewing relevant benefits before infectious disease services are delivered. For ID practices, the review may support office visits, infusions, OPAT courses, specialty drugs, and related services. The goal is to identify coverage and authorization requirements early, reducing avoidable billing confusion and unreimbursed treatment risk.

OPAT and infusion services can involve clinical care, administration, and drug billing that require careful coverage review. Eligibility verification helps the practice understand whether planned therapy is covered and whether additional authorization or documentation may be needed. Reviewing these issues before treatment supports better financial control and helps the practice avoid moving forward without a clear understanding of payer requirements.

A therapy may be processed under a medical benefit or a pharmacy benefit, and that distinction can affect authorization, billing, drug acquisition, and claim submission. Eligibility and benefits review helps identify which benefit applies to the planned service or specialty drug. For infectious disease practices, this is particularly relevant when treatment involves infusion services, OPAT, or drugs purchased and billed by the practice.

Eligibility verification can be paired with prior authorization support when a planned infusion, OPAT course, or specialty drug requires payer approval. The workflow may include identifying the applicable requirement, gathering clinical and coverage information, submitting the request, and tracking its status. Practices should also connect authorization records with scheduling, documentation, charge capture, and claims workflows.

A practice should review active eligibility, applicable benefits, coverage for the planned service, medical-versus-pharmacy benefit status, and any authorization requirements identified by the payer. For infusion and OPAT workflows, the review should also align with the drug, administration service, treatment setting, and responsible billing workflow. The exact information required varies by patient, service, and payer rules.

No. Eligibility verification can identify coverage and authorization issues before treatment, but it cannot eliminate every denial. Denials may also result from documentation, coding, medical necessity, claim submission, drug or administration billing, or payer processing issues. A stronger revenue-cycle workflow connects eligibility review with clinical documentation, coding, claim review, denial management, payment reconciliation, and accounts receivable follow-up.

Eligibility verification is an early revenue-cycle control. It occurs before or near the start of care and helps establish whether the planned service can proceed under the patient’s coverage. Its findings should flow into authorization, scheduling, documentation, coding, charge capture, billing, and follow-up. When those steps are connected, practices can better identify where coverage or reimbursement problems originated.

GrowInfectiousDisease does not publish invented Medicare rates, drug acquisition costs, payment amounts, or margin figures. Coverage and reimbursement vary by practice, payer rules, contracts, services, and other specific circumstances. The resource provides practical frameworks and tools that allow practices to apply their own numbers, evaluate revenue-cycle issues, and distinguish verified information from figures that require practice-specific confirmation.